FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

OncoCalendar

« All Events

  • This event has passed.

8th Translational Research Conference: Lymphoid Malignancies by ESH

Oct 2 • 12:00 AM - Oct 4 • 12:00 AM
8th Translational Research Conference: Lymphoid Malignancies

8th Translational Research Conference: Lymphoid Malignancies will be held at Estoril, Portugal from October 2-4, 2025.

ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives.

A distinguished faculty of international experts will lead the discussions, focusing on challenging clinical scenarios. Attendees can expect a variety of case-based discussions and debates, providing an interactive platform to explore complex issues and evolving strategies in clinical care.

For registration visit here.

 

Details

Start:
Oct 2 • 12:00 AM
End:
Oct 4 • 12:00 AM